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members, in a position that enhances and complements the vital
role of “cognitive, electrician, or plumber” HF cardiologists.
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Echocardiographic Findings in
Patients With Arrhythmogenic Right
Ventricular Cardiomyopathy/Dysplasia
We read with interest the study by Yoerger et al. (1) presenting
echocardiographic data of 29 probands affected by arrhythmogenic
right ventricular cardiomyopathy (ARVC) diagnosed with the
International Society and Federation of Cardiology task force
criteria. In all cases the echocardiogram showed typical features of
the disease. It is well known that ARVC diagnosis is made
considering different parameters. The purpose of their study was to
assess echocardiographic abnormalities in a series of patients
affected by ARVC, in whom the echocardiogram has not been
considered for the diagnosis.
Thus, we can assume that all these patients showed a clear form
of the disease, fulfilling the diagnostic criteria even in the absence
of the echocardiographic tool. However, the real problem is to
understand whether the typical ARVC echocardiographic alter-
ations have a diagnostic value per se, even when the task force
criteria (2 major, 1 major plus 2 minor, 4 minor) are not satisfied.
This point is critical because in the presymptomatic phase of the
disease the lack of diagnosis can lead to heavy consequences for the
subjects, who could be at risk of life-threatening ventricular
arrhythmias and sudden death.
Moreover, genetic studies (2) demonstrated that mutation
carriers often do not fulfill the published criteria. This leads to the
need to reevaluate the present task force criteria and to reexamine
the different echocardiographic abnormalities, trying to assess
which of these are specific to make a diagnosis of ARVC in the
absence of other codified criteria.
As shown by the investigators, a correct echocardiographic
evaluation can lead to the detection of several morphologic and
kinetic aspects of the right ventricle. At this point, considering that
an echocardiogram is a noninvasive technique that can be repeated
in time, can we consider this diagnostic tool as the “gold standard”
of ARVC diagnosis in asymptomatic patients or in patients with
minor forms of the disease (3)? Hence, the real significance of
echocardiographic abnormalities in this group of “uncertain sub-
jects” constitutes the major challenge in echocardiographic evalu-
tion of ARVC.
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REPLY
Dr. Bauce and colleagues raise several issues with regard to our
investigation of the echocardiographic findings in arrhythmogenic
right ventricular dysplasia (ARVD). The first is to indicate that our
patients all met the task force criteria for ARVD/C without the
echocardiographic-derived data. Therefore, the diagnosis was ob-
vious without the data. This was an intrinsic design of our study
(1), as one cannot assess the utility of a diagnostic method without
having a firm diagnosis of the disease excluding the test that is
being evaluated because there is no “gold standard.”
The purpose of our report was to identify the best quantitative
echocardiographic markers of ARVD in individuals meeting task
force criteria for ARVD (2). The data presented compare the
measurements of different right ventricular (RV) dimensions in
ARVD probands versus controls. We found that the right ventricular
outflow tract was the most commonly enlarged dimension in ARVD
probands. We provided a numerical value that separated the two
groups. At present, it is not uncommon for echocardiographic
laboratories to report only qualitative RV size. In order to discriminate
the normal RV from the abnormal, as is required in the assessment for
ARVD, quantitative measurements should be used.
Additionally, Dr. Bauce and colleagues correctly point out the
difficulty detecting ARVD in its preclinical or “presymptomatic”
phase. We agree that there is an important need to be able to
detect minimal structural abnormalities of the RV in patients
suspected of ARVD. Upon its completion, the Multidisciplinary
Registry of ARVD will have quantitative data from echocardio-
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